首页> 外文期刊>Nephron >Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A.
【24h】

Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A.

机译:有和没有环孢菌素A治疗的肾移植患者的肾小球和肾小管功能。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study evaluated whether chronically administered low-dose (<5 mg/kg) ciclosporin A (CsA) affects renal haemodynamics and tubular function in renal transplant recipients (RTx) when studied at nadir CsA blood levels. The renal clearance of lithium was used as an index of proximal tubular outflow of sodium and water. Effective renal plasma flow, glomerular filtration rate, and renal clearance of lithium were studied in 67 stable non-diabetic RTx and 44 healthy controls. Forty-eight of the RTx were treated with CsA, prednisone, and azathioprine. Nineteen were treated exclusively with prednisone and azathioprine. In RTx with a good graft function (serum-creatinine <125 micromol/l), no specific CsA-induced renal haemodynamic and tubular dysfunctions were evident. In CsA-treated RTx with a slightly reduced renal function (serum creatinine 125-180 micromol/l) a decrease in fractional proximal tubular reabsorption was found. The renal clearances of urate and magnesium were comparable between RTx treated with or without CsA, and a significant correlation between glomerular filtration rate and renal clearance of urate was found. CsA-treated RTx had a significantly higher blood pressure, independent of glomerular filtration rate and segmental tubular function. In conclusion, at nadir CsA blood levels, no specific CsA-induced tubular dysfunction evaluated by the renal lithium clearance method could be demonstrated in RTx receiving chronically low-dose CsA. The hyperuricaemia commonly seen in RTx seems to be mainly caused by the reduced glomerular filtration rate.
机译:本研究评估了在最低CsA血液水平下进行研究时,长期服用小剂量(<5 mg / kg)的环孢素A(CsA)是否会影响肾移植受者(RTx)的肾血流动力学和肾小管功能。锂的肾清除率用作钠和水近端肾小管流出的指标。在67个稳定的非糖尿病性RTx和44个健康对照中研究了有效的肾脏血浆流量,肾小球滤过率和锂的肾脏清除率。 RTx的四十八个分别用CsA,泼尼松和硫唑嘌呤处理。 19例仅用泼尼松和硫唑嘌呤治疗。在具有良好移植功能的RTx(血清肌酐<125微摩尔/升)中,没有明显的CsA诱导的肾血流动力学和肾小管功能障碍。在经CsA处理的RTx中,肾功能略有降低(血清肌酐为125-180 micromol / l),近端小管重吸收分数降低。在使用或不使用CsA的RTx治疗下,尿酸盐和镁的肾脏清除率相当,并且发现肾小球滤过率与尿酸盐的肾脏清除率之间存在显着相关性。经CsA处理的RTx的血压明显升高,与肾小球滤过率和节段性肾小管功能无关。总之,在最低CsA血药浓度下,接受长期低剂量CsA的RTx尚无通过肾脏锂清除法评估的由CsA引起的特定肾小管功能障碍。 RTx中常见的高尿酸血症似乎主要是由肾小球滤过率降低引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号